3.4. Niclosamide Effectively Mitigated IGF-1R and OCT4 Expressions as Well as Sorafenib-Induced IGF-1R Phosphorylation in the Sorafenib-Resistant HCC Cells under IGF-1 Treatment. Here, IGF1 is linked to hepatocellular carcinoma.